Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.
Takahashi R, Ishibashi Y, Hiraoka K, Matsueda S, Kawano K, Kawahara A, Kage M, Ohshima K, Yamanaka R, Shichijo S, Shirouzu K, Itoh K, Sasada T.
Takahashi R, et al. Among authors: kawano k.
Cancer Sci. 2013 Oct;104(10):1285-94. doi: 10.1111/cas.12226. Epub 2013 Aug 6.
Cancer Sci. 2013.
PMID: 23829867
Free PMC article.
Clinical Trial.